From ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer:

Neutrophils and T cells with mAbXcite

Neutrophils and T cells with mAbXcite—

A description of the immune response generated by Lexington, MA-based ImmuneXcite’s “mAbXcite” technology.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Xconomy on Demand

We offer a number of ways to subscribe for free!